An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma

被引:142
作者
Friedman, DS
Wilson, MR
Liebmann, JM
Fechtner, RD
Weinreb, RN
机构
[1] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79409 USA
[3] NYU, Sch Med, Manhattan Eye Ear & Throat Hosp, New York, NY USA
[4] Univ Med & Dent New Jersey, New Jersey Med Sch, Inst Ophthalmol & Visual Sci, Newark, NJ 07103 USA
[5] Univ Calif San Diego, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA
关键词
D O I
10.1016/j.ajo.2004.04.058
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To critically review the existing literature concerning risk factors for progression of ocular hypertension and glaucoma to assist in assigning levels of risk for individual patients. DESIGN: Evidence-based review. METHODS: A panel of physicians specializing in treatment of glaucoma patients was convened to critically analyze published population,based studies of ocular hypertension and glaucoma progression. The strength of evidence in support of reported risk factors was weighed. RESULTS: Many putative risk factors for progression of ocular hypertension or glaucoma have been reported in the literature. The risk factors most strongly supported by evidence are higher intraocular pressure (IOP), greater cup,to-disk ratio, thinner central corneal measurement, and older age. Black race does not appear to be an independent risk factor, although black individuals tend to have thinner corneas, greater cup-to,disk ratios, and higher IOP, which increase their risk. The limited number of studies in which other suspected risk factors are reported prevents drawing firm conclusions about their importance at this time. 0 CONCLUSIONS: Only a subset of patients with ocular hypertension will eventually develop glaucoma. Decisions regarding the implementation and extent of therapy for ocular hypertension can be difficult and require an understanding of the relative importance of risk factors for progression. This review discusses the strength of evidence supporting reported risk factors and may be useful in assessing the risk for progression of individual patients. (C) 2004 by Elsevier Inc. All rights reserved.
引用
收藏
页码:S19 / S31
页数:13
相关论文
共 48 条
  • [11] Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714
  • [12] Graham P A, 1969, Trans Ophthalmol Soc U K, V88, P153
  • [13] THE PERITEST, A NEW AUTOMATIC AND SEMIAUTOMATIC PERIMETER
    GREVE, EL
    DANNHEIM, F
    BAKKER, D
    [J]. INTERNATIONAL OPHTHALMOLOGY, 1982, 5 (03) : 201 - 214
  • [14] Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
    Grundy, SM
    Pasternak, R
    Greenland, P
    Smith, S
    Fuster, V
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) : 1348 - 1359
  • [15] Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial
    Heijl, A
    Bengtsson, B
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2000, 238 (11) : 877 - 883
  • [16] Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial
    Heijl, A
    Leske, MC
    Bengtsson, B
    Hyman, L
    Bengtsson, B
    Hussein, M
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) : 1268 - 1279
  • [17] Hulsman CAA, 2002, ARCH OPHTHALMOL-CHIC, V120, P1726
  • [18] Baseline visual field characteristics in the ocular hypertension treatment study
    Johnson, CA
    Keltner, JL
    Cello, KE
    Edwards, M
    Kass, MA
    Gordon, MO
    Budenz, DL
    Gaasterland, DE
    Werner, E
    [J]. OPHTHALMOLOGY, 2002, 109 (03) : 432 - 437
  • [19] RISK-FACTORS FAVORING THE DEVELOPMENT OF GLAUCOMATOUS VISUAL-FIELD LOSS IN OCULAR HYPERTENSION
    KASS, MA
    HART, WM
    GORDON, M
    MILLER, JP
    [J]. SURVEY OF OPHTHALMOLOGY, 1980, 25 (03) : 155 - 162
  • [20] Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701